Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.

By J. O'connell, M. Maggard, C. Ko. Journal of the National Cancer Institute, 2005

1,498 citations recorded by the source corpus.

Subfields: Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/06739cccb6439c212011b4d05e0b5a4f7214de6d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. Bert Vogelstein
2. Kenneth W. Kinzler
3. M. López-Lázaro

In Pathology and Forensic Medicine

1. L. Diaz
2. Kenneth W. Kinzler
3. Bert Vogelstein
4. A. Bardelli
5. Benjamin L. Ebert
6. Siddhartha Jaiswal

Citations in the corpus

• Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer (2016, background): “Conversely, patients with negative ctDNA postoperatively were at a low risk of radiologic recurrence (3-year RFS of 90%), not dissimilar to patients with stage I colorectal cancer (35), defining a group where adjuvant therapy is less likely to be helpful.”